In an expert Q&A, Hospital for Special Surgery’s Lisa Mandl, MD, MPH, discusses the role of genicular nerve ablation in ...

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

Studies show exercise, braces, and water therapy can reduce pain and improve mobility for millions with knee arthritis.

Researchers in China have found no statistically significant advantage for infrapatellar fat pad glucocorticoid injection ...

Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the US Food and Drug Administration (FDA) has accepted ...

Stem cell treatment targeting the bone beneath the knee reduced pain and improved movement more effectively than joint ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

A study in mice by researchers from Stanford University has traced the loss of cartilage that comes with aging to a single ...

In a revolutionary discovery, scientists have identified a specific protein that, when blocked, allows the body to naturally ...

According to Mayo Clinic, stem cells are a special type of cell that have two important properties that make more cells like ...

Stanford researchers have discovered that inhibiting a protein called 15-PGDH in mice can reverse age-related cartilage loss, ...

A novel cartilage-regenerating injection blocks age-related degeneration pathways and shows potential to prevent osteoarthritis beyond pain control.